Photodynamic Therapy With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

Trial Profile

Photodynamic Therapy With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 14 Jan 2014

At a glance

  • Drugs Temoporfin (Primary)
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Jan 2014 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
    • 11 Sep 2012 Planned end date changed from 1 Jul 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
    • 18 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top